Results 91 to 100 of about 547 (137)

IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery: Preclinical studies in orthotopic xenografts. [PDF]

Theranostics, 2021
Kurbegovic S, Juhl K, Sørensen KK, Leth J, Willemoe GL, Christensen A, Adams Y, Jensen AR, von Buchwald C, Skjøth-Rasmussen J, Ploug M, Jensen KJ, Kjaer A.   +12 more
europepmc   +1 more source

Implementation of safety management system for the domestic fleet in Myanmar [PDF]

, 2021
Ko Ko Zin,
core   +1 more source

Personalized Targeted Therapeutic Strategies against Oral Squamous Cell Carcinoma. An Evidence-Based Review of Literature. [PDF]

Int J Nanomedicine, 2022
Cao M, Shi E, Wang H, Mao L, Wu Q, Li X, Liang Y, Yang X, Wang Y, Li C.   +9 more
europepmc   +1 more source

Inflammatory biomarkers and cancer:CRP and suPAR as markers of incident cancer in patients with serious nonspecific symptoms and signs of cancer [PDF]

, 2017
David, Kim Peter, Eugen-Olsen, Jesper, Gaardsting, Anne, Garred, Peter, Helms, Morten, Iversen, Kasper, Kjaer, Andreas, Kronborg, Gitte, Ladelund, Steen, Lebech, Anne-Mette, Rasmussen, Line Jee Hartmann, Schultz, Martin   +11 more
core   +1 more source

Phase II study of uPAR-PET/CT for staging of primary breast cancer in comparison with ultrasound and fine needle biopsies. [PDF]

Sci Rep
Fosbøl MØ, Carlsen EA, Brandt-Larsen M, Christensen C, Madsen J, Loft A, Berthelsen AK, Tvedskov TF, Kroman N, Andersen KF, von Benzon E, Kjaer A.   +11 more
europepmc   +1 more source

The Urokinase-Type Plasminogen Activator Receptor (uPAR) as a Mediator of Physiological and Pathological Processes: Potential Therapeutic Strategies. [PDF]

Cancers (Basel)
Iftikhar A, Mahmood N, Rabbani SA.
europepmc   +1 more source

Dysregulated fibrinolysis and plasmin activation promote the pathogenesis of osteoarthritis. [PDF]

JCI Insight
Wang Q, Shao G, Zhao X, Wong HH, Chin K, Zhao M, Bai A, Bloom MS, Love ZZ, Chu CR, Cheng Z, Robinson WH.   +11 more
europepmc   +1 more source

The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets. [PDF]

Biomolecules, 2022
Kumar AA, Buckley BJ, Ranson M.
europepmc   +1 more source

Photo-Click-Facilitated Screening Platform for the Development of Hetero-Bivalent Agents with High Potency. [PDF]

J Org Chem, 2020
Sun L, Gai Y, McNitt CD, Sun J, Zhang X, Xing W, Li Z, Popik VV, Zeng D.   +8 more
europepmc   +1 more source

Molecular targets and the emerging role of copper radionuclides in prostate cancer theranostics. [PDF]

EJNMMI Res
Rodrigues D, Fonseca AI, Moreira JN, Gomes C, Abrunhosa A.   +4 more
europepmc   +1 more source